1. Home
  2. AKTX vs NXPL Comparison

AKTX vs NXPL Comparison

Compare AKTX & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AKTX
  • NXPL
  • Stock Information
  • Founded
  • AKTX N/A
  • NXPL 1997
  • Country
  • AKTX United States
  • NXPL United States
  • Employees
  • AKTX N/A
  • NXPL N/A
  • Industry
  • AKTX Biotechnology: Pharmaceutical Preparations
  • NXPL Telecommunications Equipment
  • Sector
  • AKTX Health Care
  • NXPL Telecommunications
  • Exchange
  • AKTX Nasdaq
  • NXPL Nasdaq
  • Market Cap
  • AKTX 34.7M
  • NXPL 32.5M
  • IPO Year
  • AKTX N/A
  • NXPL N/A
  • Fundamental
  • Price
  • AKTX $1.24
  • NXPL $0.98
  • Analyst Decision
  • AKTX
  • NXPL
  • Analyst Count
  • AKTX 0
  • NXPL 0
  • Target Price
  • AKTX N/A
  • NXPL N/A
  • AVG Volume (30 Days)
  • AKTX 26.3K
  • NXPL 152.4K
  • Earning Date
  • AKTX 02-15-2025
  • NXPL 11-14-2024
  • Dividend Yield
  • AKTX N/A
  • NXPL N/A
  • EPS Growth
  • AKTX N/A
  • NXPL N/A
  • EPS
  • AKTX N/A
  • NXPL N/A
  • Revenue
  • AKTX N/A
  • NXPL $66,482,000.00
  • Revenue This Year
  • AKTX N/A
  • NXPL N/A
  • Revenue Next Year
  • AKTX N/A
  • NXPL N/A
  • P/E Ratio
  • AKTX N/A
  • NXPL N/A
  • Revenue Growth
  • AKTX N/A
  • NXPL 179.89
  • 52 Week Low
  • AKTX $0.90
  • NXPL $0.71
  • 52 Week High
  • AKTX $4.40
  • NXPL $2.68
  • Technical
  • Relative Strength Index (RSI)
  • AKTX 51.97
  • NXPL 45.18
  • Support Level
  • AKTX $1.10
  • NXPL $0.98
  • Resistance Level
  • AKTX $1.39
  • NXPL $1.08
  • Average True Range (ATR)
  • AKTX 0.13
  • NXPL 0.10
  • MACD
  • AKTX -0.00
  • NXPL -0.02
  • Stochastic Oscillator
  • AKTX 61.54
  • NXPL 18.75

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).

About NXPL NextPlat Corp

NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.

Share on Social Networks: